Bevacizumab (Avastin) for Ocular Disorders


Shweta Walia, P. Varma




Abnormal ocular neovascularization is major cause of loss of vision.The newly formed vessels are dysfunctional which can leak fluid, cause hemorrhage, or are associated with fibrous proliferation,  resulting in potentially catastrophic loss of vision. Anti VEGF have come as a boon to cure ocular neovascularization. This paper will describe the attempted uses of  bevacizumab , humanized monoclonal antibody to VEGF, for various ocular disorders  and its efficacy in addition to discussing safety. Comments regarding appropriate use of this treatment are based on our current level of knowledge and large ,randomized control studies  are required to expand the use of this wonderful drug.




neovascularization; VEGF; anti VEGF; bevacuzimab


Full Text:



Article Metrics

Metrics Loading …

Metrics powered by PLOS ALM


  • There are currently no refbacks.


Copyright (c) 2014 International Journal of Pharmacological Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Dr. Jun Ren is a dedicated and experienced registered dietitian and nutritionist who is committed to helping people achieve their health goals through personalized nutrition plans. With a passion for promoting healthy eating habits and preventing chronic diseases, Dr. Ren has been able to assist numerous clients in improving their overall quality of life.

Leave a Comment